glp-1 obesity drugs news today 2025 trends 2025: real-world data, patient outcomes & future therapies How Supply and Demand for
Description
doi: 10.1023/a:1018863716749
GRP stimulation of GLP-1 secretion has also been demonstrated for rat L-cell cultures and in preparations of rat ileum [323,335]
A., Hingson, R
Kidney transplant patients taking GLP-1 drugs had a 49% greater risk of developing diabetic retinopathy, a potentially blinding condition caused by damage to the light-sensitive tissue lining the back of the eyes
Noom is the broader weight-loss program and medication-support ecosystem
The FDA approval process exists for a reason: to protect us from these uncertainties
